Literature DB >> 17626736

Differential expression of capillary VEGF isoforms following traumatic brain injury.

Paula Dore-Duffy1, Xueqain Wang, Afroza Mehedi, Christian W Kreipke, José A Rafols.   

Abstract

OBJECTIVES: While it is known that angiogenesis occurs after trauma, we sought to characterize the expression of vascular endothelial growth factor (VEGF) subtypes, vascular endothelial growth factor receptor 2 (VEGFR2) and angiopoietin within capillaries of animals subjected to traumatic brain injury (TBI). Further, we sought to characterize pericyte cell death in isolated capillaries.
METHODS: We used Marmarou's acceleration impact model to induce head trauma and measured VEGF, VEGFR2 and angiopoietin levels in isolated capillaries. TUNEL was used to determine pericyte cell death.
RESULTS: The VEGF response was restricted to the VEGF120 isoform. No increase in transcripts for VEGF164 and VEGF188 was observed. VEGFR2 was marginally increased and angiopoietin was increased. A subset of pericytes were TUNEL-positive. DISCUSSION: These results show a distinct expression pattern of angiogenic factors following injury and suggest that pericyte involvement in adaptive angiogenesis may be altered following TBI.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17626736     DOI: 10.1179/016164107X204729

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  25 in total

1.  Immortalized CNS pericytes are quiescent smooth muscle actin-negative and pluripotent.

Authors:  Paula Dore-Duffy; Afroza Mehedi; Xueqian Wang; Michael Bradley; Richard Trotter; Alexander Gow
Journal:  Microvasc Res       Date:  2011-04-15       Impact factor: 3.514

Review 2.  Cell-specific blood-brain barrier regulation in health and disease: a focus on hypoxia.

Authors:  S Engelhardt; S Patkar; O O Ogunshola
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

3.  Combination of vascular endothelial and fibroblast growth factor 2 for induction of neurogenesis and angiogenesis after traumatic brain injury.

Authors:  Orli Thau-Zuchman; Esther Shohami; Alexander G Alexandrovich; Ronen R Leker
Journal:  J Mol Neurosci       Date:  2012-01-13       Impact factor: 3.444

4.  Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor.

Authors:  Ye Xiong; Yanlu Zhang; Asim Mahmood; Yuling Meng; Changsheng Qu; Michael Chopp
Journal:  Transl Stroke Res       Date:  2011-12-01       Impact factor: 6.829

Review 5.  The Medical Management of Cerebral Edema: Past, Present, and Future Therapies.

Authors:  Michael R Halstead; Romergryko G Geocadin
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 6.  Aquaporin 4 in Traumatic Brain Injury: From Molecular Pathways to Therapeutic Target.

Authors:  Ehsan Dadgostar; Shiva Rahimi; Shahin Nikmanzar; Sina Nazemi; Mojtaba Naderi Taheri; Zahra Alibolandi; Michael Aschner; Hamed Mirzaei; Omid Reza Tamtaji
Journal:  Neurochem Res       Date:  2022-01-28       Impact factor: 3.996

7.  Vascular endothelial growth factor increases neurogenesis after traumatic brain injury.

Authors:  Orli Thau-Zuchman; Esther Shohami; Alexander G Alexandrovich; Ronen R Leker
Journal:  J Cereb Blood Flow Metab       Date:  2010-01-13       Impact factor: 6.200

Review 8.  Pericytes of the neurovascular unit: key functions and signaling pathways.

Authors:  Melanie D Sweeney; Shiva Ayyadurai; Berislav V Zlokovic
Journal:  Nat Neurosci       Date:  2016-05-26       Impact factor: 24.884

9.  Hypoxia alters MicroRNA expression in rat cortical pericytes.

Authors:  Jessie S Truettner; Vladimir Katyshev; Nilufer Esen-Bilgin; W Dalton Dietrich; Paula Dore-Duffy
Journal:  Microrna       Date:  2013

10.  Intravenous injection of neural progenitor cells facilitates angiogenesis after cerebral ischemia.

Authors:  Yoshiyuki Moriyama; Norio Takagi; Kanae Hashimura; Chisa Itokawa; Kouichi Tanonaka
Journal:  Brain Behav       Date:  2012-12-28       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.